Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia
- 16 October 2003
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (9) , 909-913
- https://doi.org/10.1038/sj.bmt.1704244
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overloadThe Lancet, 2002
- Hemochromatosis Gene in Leukemia and LymphomaLeukemia & Lymphoma, 2002
- Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignanciesAmerican Journal of Hematology, 1999
- Iron overload in bone marrow transplant recipientsBone Marrow Transplantation, 1998
- Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trialThe Lancet, 1998
- The Significance of the 187G (H63D) Mutation in HemochromatosisAmerican Journal of Human Genetics, 1997
- Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation.Journal of Clinical Pathology, 1996
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996
- Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload.Journal of Clinical Pathology, 1982
- Ferritin Synthesis in Inflammation: I. PATHOGENESIS OF IMPAIRED IRON RELEASEBritish Journal of Haematology, 1977